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Abstract 46 
Introduction 47 
Chronic heart failure (CHF) is characterized by dyspnea and poor exercise tolerance, which 48 
decreases aerobic capacity (V̇O2peak), a measure strongly correlated with quality of life and 49 
mortality. In healthy populations, eccentric (ECC) cycling can be performed at a lower 50 
oxygen demand for matched workload, compared to concentric (CON) cycling, but few 51 
studies have previously investigated ECC cycling in CHF. We hypothesized that, when 52 
matched for external workload (Watts), an ECC cycling bout would be performed at a lower 53 
cardiorespiratory load (V̇O2) than CON in patients with CHF. 54 
Methods 55 
Eleven CHF patients (10 males) with impaired left ventricular systolic function (ejection 56 
fraction 31±12%) completed a CON V̇O2peak test, with the subsequent ECC and CON 57 
protocols set at 70% of individual maximal CON power (Watts). Oxygen consumption 58 
(V̇O2), respiratory exchange ratio (RER), minute ventilation (V̇E), heart rate (HR) and rate 59 
pressure product (RPP) were compared between conditions.  60 
Results 61 
ECC was performed at a lower V̇O2 (12.3±1.3 vs. 14.1±0.8 mL.kg-1min-1, P=0.01), RER 62 
(0.92±0.02 vs. 0.96±0.01, P=0.01) and V̇E (36.5±4.4 vs. 40.2±2.0 L/min, P=0.04) in 63 
comparison to CON, despite both conditions being performed at matched workloads. Heart 64 
rate (101±5 vs. 96±1 bpm; P=0.06) and RPP (13,539±788 vs. 11,911±227 bpm.mmHg-1, 65 
P=0.15) were not significantly different between conditions.  66 
Conclusion 67 
When matched for external workload, ECC cycling can be performed with a lower oxygen 68 
demand than CON in patients with CHF. Eccentric cycling is a promising modality for 69 
cardiac rehabilitation in severely deconditioned patients with CHF. 70 
 71 
Keywords: exercise, cardiac rehabilitation, oxygen uptake, exercise rehabilitation. 72 
 73 
Introduction 74 
Chronic heart failure (CHF) is a major global health burden (28). By 2030, the prevalence of 75 
CHF is expected to increase a further 23% due to rising levels of obesity and diabetes, 76 
alongside improved survival following myocardial infarction (19, 29). Hallmark symptoms of 77 
CHF are dyspnea and fatigue on exertion (7), leading to impaired functional independence, 78 
compromised quality of life and increased morbidity and mortality (32). 79 
 80 
It is well established that peripheral abnormalities represent a locus of fatigue in CHF. The 81 
sequelae of CHF involving sympathetic nervous system activation, increased inflammatory 82 
cytokine release and excessive peripheral vasoconstriction (21), are associated with a 83 
generalized skeletal muscle myopathy, which worsens as the disease progresses (3). First 84 
conceptualized in 1996 by Coats et al. (8), the ‘muscle hypothesis’ proposes that the 85 
activation of skeletal muscle metaboreceptors may underpin exertional dyspnea and fatigue, 86 
and by way of a feedback loop, contribute to deteriorating left ventricular function. This 87 
creates a vicious cycle whereby worsening exercise intolerance and subsequent 88 
deconditioning induce further exacerbation of the condition.  89 
 90 
However, such abnormalities in skeletal muscle function and blood flow are amenable to 91 
exercise-mediated improvement (10, 18, 24, 25). Exercise training has shown to increase 92 
aerobic capacity (V̇O2peak) in patients with CHF (13, 15, 31), a significant clinical finding 93 
given that this measure is a strong prognostic indicator (9, 26). Exercise-based rehabilitation 94 
programs are now an established component of CHF management worldwide, decreasing 95 
hospitalizations, increasing health-related quality of life and possibly reducing long-term 96 
mortality (31). 97 
Conventionally, exercise training for patients with CHF has utilized concentric exercise such 98 
as cycling, in which prime movers (e.g. knee extensors) shorten in pedalling. However, it can 99 
be challenging to prescribe concentric cycling (CON) at an intensity sufficient to induce 100 
peripheral adaptations, without causing dyspnea and fatigue in patients with more severe 101 
CHF. An exercise modality that enables a greater localized stimulus to the muscle, without 102 
increased cardiovascular demand, may provide an alternative pathway to attenuate skeletal 103 
muscle abnormalities in CHF. 104 
 105 
Eccentric cycling (ECC) possesses unique characteristics that differ from CON, making it a 106 
potentially efficacious and clinically relevant alternative for CHF patients. In healthy young 107 
males, at the same mechanical intensity (Watts), metabolic intensity (V̇O2) is significantly 108 
lower when cycling eccentrically versus concentrically (36). The mechanisms underpinning 109 
this phenomenon are not fully understood, but are likely the result of complex molecular 110 
events resulting in less adenosine triphosphate (ATP) usage during ECC versus CON 111 
exercise (20, 33). 112 
 113 
As skeletal muscle has been identified as a key locus of exercise intolerance in patients with 114 
CHF (34, 35), ECC may enable exercise to be performed at higher mechanical intensities 115 
resulting in clinically important peripheral adaptations, without eliciting significant 116 
symptoms. However, there is a paucity of literature comparing the acute effects of ECC and 117 
CON cycling in patients with CHF, particularly studies in which the intensity of the sessions 118 
is well matched. The aim of this study was to compare, in patients with CHF, the oxygen 119 
demand associated with ECC and CON cycling performed at matched workloads. We 120 
hypothesized that, when matched for power output (W), patients with CHF would be able to 121 
perform an ECC cycling bout at a lower V̇O2 in comparison to CON. 122 
 123 
Methods 124 
Participants 125 
Eleven participants with CHF NYHA class I to III with a reduced left ventricular systolic 126 
function (ejection fraction <45%) who provided written informed consent were recruited 127 
from Fiona Stanley Hospital. Ethics approval for the study was provided by the Royal Perth 128 
Hospital Human Research Ethics Committee (HREC 14-160). Medical screening, performed 129 
by a cardiologist, occurred before participants were accepted into the study. Participants were 130 
excluded from the study if they met any of the following criteria: resting hypertension 131 
(>165/95 mmHg), severe obstructive aortic valve stenosis, severe heart rhythm disorder 132 
excluding safe participation in exercise, severe pulmonary hypertension (>70 mmHg), venous 133 
thromboembolic history within the past three months, musculoskeletal comorbidity limiting 134 
functional capacity beyond the CHF itself or inability to provide informed consent. As this 135 
was a trial of patients undergoing routine medical therapy, heart failure medications did not 136 
constitute exclusion. There were no changes in medication regimens or episodes of heart 137 
failure decompensation during the course of the study. 138 
 139 
Experimental design 140 
Participants performed a medically supervised graded exercise test (GXT) on a conventional 141 
electronically braked recumbent cycle ergometer (Corival, Lode BV, Groningen, The 142 
Netherlands) with breath by breath V̇O2 and minute ventilation (V̇E) measured via indirect 143 
calorimetry (Vyntus CPX, Jaeger, CareFusion, Germany) and respiratory exchange ratio 144 
(RER) calculated automatically. Heart rate (HR) and rhythm were constantly monitored by 145 
12-lead electrocardiogram (ECG). Stages were three minutes in duration and cycling was 146 
maintained at a cadence of 60 revolutions per minute (rpm) with workload increased by 20 W 147 
increments. Blood pressure was measured manually in the final minute of each stage and the 148 
assessment was terminated when the participant reached volitional exhaustion. 149 
Seven days after the GXT, participants performed an ECC cycling session. To familiarise the 150 
participants with ECC cycling, each engaged in a short (three minute) familiarisation ECC 151 
cycling bout consisting of 30 s without any load, followed by one minute at 30% of Wmax 152 
(from GXT) and then one minute aiming for 70% Wmax and a further 30 s without any load. 153 
When HR and V̇O2 had returned to baseline levels, participants performed a three minute 154 
warm-up (30% of Wmax), followed by five minutes at a workload equivalent to 70% of 155 
maximum CON workload (W) achieved during the GXT.  Due to the oscillatory nature of 156 
ECC cycling, the ECC session was always conducted first with workload averaged across 157 
each 30 s period. This way, we were able to alter the workload during every 30 sec during the 158 
CON session, to match the two conditions for power output (see Figure 1). Seven days later, 159 
a CON session was performed, during which workload was matched to the ECC session. The 160 
ECC and CON sessions were performed at the same time of day to help ensure medications 161 
influenced the sessions equally.  162 
 163 
In the current study, we matched the ECC and CON sessions based on workload, similar to 164 
our previous work by Penailillo et al. (36). Because of the limited exercise capacity of the 165 
participants in the present study, we minimized the exercise time to 5 min, but set the 166 
intensity at 70% Wmax to compare between ECC and CON. Our pilot studies in healthy young 167 
participants showed that when eccentric cycling duration is ~ less than 5 minutes, muscle 168 
damage characterized by delayed onset muscle soreness and prolonged strength loss is 169 
minimal.  Based on this observation, we surmised that 5-min eccentric cycling would not 170 
induce significant muscle soreness in our CHF cohort. The workload chosen in this study 171 
equated to ~75% VO2peak, which is at the upper end of the range for continuous aerobic 172 
exercise prescription for patients with CVD, as recommended by the ACSM (2).  173 
 174 
Eccentric cycling (ECC) protocol 175 
On arrival at the lab participants were attached to a 12-lead ECG and resting HR, rhythm and 176 
BP recorded. Participants were given an explanation as to how to operate the ECC ergometer. 177 
Eccentric cycling was performed on a recumbent ergometer (Eccentric Trainer, Metitur, Ltd, 178 
Jyväskylä, Finland) with a 1.5 kW motor that powered the cranks in reverse. A target power 179 
output line was calculated for each participant and displayed on a screen. Actual power 180 
output was visually and numerically displayed on screen as a feedback mechanism for 181 
participants. Cadence was set at 40 rpm to account for the difficulty in performing higher 182 
cadence ECC cycle ergometer contractions.  183 
 184 
A metabolic cart (Vyntus CPX, Jaeger, CareFusion, Germany) was used to measure oxygen 185 
uptake and participants performed a three minute warm up, aiming for a power output 186 
correlating to 30% Wmax achieved during GXT. Following this, participants were instructed 187 
to increase their wattage to 70% of Wmax for a further five minutes. Heart rate, V̇O2 (ml.kg.-188 
1.min1), V̇E and RER were averaged across 10 s epochs with BP recorded at 1:30 and 4:30 of 189 
the five minute protocol. This was followed by a three minute cool down during which 190 
participants were instructed to keep their legs turning without applying any resistance.  191 
 192 
Concentric (CON) cycling protocol  193 
One week following the ECC session, participants completed a CON session using the 194 
conventional recumbent cycle ergometer mentioned above, with resistance (W) adjusted 195 
every 30 s to match workload attained during the ECC session. Participants were instructed to 196 
cycle at 40 rpm. Identical measurements to those outlined in the ECC session were recorded. 197 
 198 
Other measures 199 
A visual analogue scale (VAS; 10-cm line, 0: no pain, 10: worst possible pain) was used to 200 
assess exercise muscle soreness in the quadriceps muscles pre, immediately post, 1, 24, 48 201 
and 72 hours after each exercise session as a marker of muscle damage. Blood lactate (BLa) 202 
was measured before, immediately after and five minutes after each exercise by obtaining 203 
blood samples from the fingertip using a Lactate Pro 2 (Arkay Inc., Japan).  204 
 205 
Statistical analyses 206 
An a-priori sample size calculation was calculated from Meyer. et al. (27), using an effect 207 
size of 3.74, power of 0.8 and p = 0.01. This calculation indicated that a minimum sample 208 
size of 8 was required.  All results were analysed using SPSS (Version 20.0, IBM, USA) and 209 
expressed as means ± SD. As CON workload was manipulated every 30 s in order to closely 210 
match it to the ECC workload of the previous session, average values for the final 10 s of 211 
each 30 s epoch for V̇O2, HR, RER and V̇E were recorded. These values were averaged 212 
across each minute of the exercise session to provide an overall average for the five minute 213 
protocol. Statistical analyses for the above measures were conducted using these values. 214 
Paired, two tailed t-tests were used to analyse the differences in outcome measures between 215 
the two exercise protocols. For all analyses, statistical significance was set at p ≤ 0.05.  216 
Results 217 
Participant characteristics 218 
Participant characteristics are presented in Table 1. Five participants had ischemic 219 
cardiomyopathy and six had non-ischemic cardiomyopathy as their primary diagnosis. 220 
Medications remained unchanged throughout the course of the study. Each participant 221 
completed all sessions without any adverse responses. 222 
 223 
Comparison of ECC and CON sessions 224 
Respiratory variables 225 
Across the exercise period, V̇O2 was lower (P=0.01) in ECC (12.3 ± 1.3 ml.kg-1.min-1) than 226 
CON (14.1 ± 0.8 ml.kg-1.min-1, Figure 2).  227 
 228 
Respiratory exchange ratio (RER) was lower during ECC (0.92 ± 0.02) than CON (0.96 ± 229 
0.01, P=0.01). Similarly, V̇E was also significantly lower during ECC (36.5± 4.4 vs. 40.2±2.0 230 
L/min, P=0.04). The average change in blood lactate (BLa) from pre to immediately post 231 
exercise was similar between conditions (1.5 ± 3.7 vs. 2.7 ± 3.8  mmol/L, P=0.46).  232 
 233 
Hemodynamic variables 234 
Heart rate (HR) was not statistically different during ECC (101 ± 5 bpm) and CON (96 ± 1 235 
bpm, P=0.06). Similarly, there were no differences in mean arterial pressure (92 ± 1 vs. 89 ± 236 
2 mmHg, P=0.34) or rate pressure product (RPP) (13,539 ± 788 vs. 11,911 ± 227 237 
bpm.mmHg-1,
 P=0.15) between conditions. 238 
 239 
Muscle soreness 240 
No significant difference in muscle soreness existed between ECC and CON before and 241 
immediately after exercise (0.82 ± 1.4 vs. 0.82 ± 1.3 cm). Muscle soreness was significantly 242 
higher 24 hours (3.0 ± 3.1 vs. 0.5 ± 0.9 cm, P=0.02) and 48 hours after ECC exercise 243 
compared to CON (2.1 ± 2.1 vs. 0.9 ± 0.7 cm, P=0.01), but this difference diminished 72 244 
hours post-exercise (0.5 ± 2.0 vs. 0.0 ± 0.4 cm, P=0.38).  245 
 246 
 247 
Discussion 248 
The principal finding of this study is that, when matched for workload, V̇O2 was significantly 249 
(~13%) lower during ECC compared to CON cycling in patients with CHF.  This is 250 
consistent with previous research in healthy populations reporting lower V̇O2 responses to 251 
ECC than CON when matched for workload (1, 11, 36). ECC did not evoke significantly 252 
higher cardiovascular demand, with similar HR, BP and RPP responses, to CON. The 253 
corollary is that, for a given V̇O2, higher workloads can be attained during ECC. Exercise 254 
that elicits a higher localized muscular stimulus, in the absence of increased cardiovascular 255 
demand, is a clinically relevant finding for patients with CHF in whom skeletal muscle 256 
maladaptations contribute significantly to exercise intolerance and impaired aerobic capacity 257 
(14). 258 
 259 
Some previous studies have compared ECC and CON in clinical populations (4, 5, 17, 27, 38, 260 
40). These studies are broadly consistent with our data, in that they report higher power 261 
outputs during ECC. Besson et al. (4) concluded that ECC was a safe alternative to CON in 262 
CHF, inducing functional improvements in 6 min walk time following a seven week ECC 263 
training program. Using the same protocol, the group conducted a follow up study concluding 264 
that ECC induced similar improvements in maximal capacity and superior strength (triceps 265 
surae) increases compared to CON (5).  However, in both studies, workload (W) was 266 
subjectively matched between conditions. Theodorou et al. (40) assessed the effect of ECC 267 
exercise in participants with CHF via stair descending and ascending exercise. Eccentric and 268 
isometric torque was reported to be greater in the ascending group, with concentric torque 269 
similar between conditions. Although, the aforementioned studies used a between-subjects 270 
design and individual differences may partially explain the results. The present study is 271 
therefore the first, to our knowledge, to closely match intensity between conditions and use a 272 
within-subjects design, allowing valid comparisons to be made between the acute responses 273 
to ECC and CON cycling in individuals with CHF. 274 
 275 
In addition to a lower V̇O2 response, we also observed significantly lower V̇E and RER 276 
values during ECC. These results indicate that, when matched for workload, ECC can be 277 
performed with a lower respiratory demand compared to CON. One of the mechanisms that 278 
may be responsible for the lower oxygen demand involves actin-myosin cross-bridge cycling. 279 
During ECC contractions some cross-bridges are forcibly detached, allowing ATP to be 280 
stored, thereby lowering metabolic cost (33). Achieving a similar exercise workload with a 281 
significantly lower oxygen demand is a clinically relevant and novel finding for CHF 282 
patients, who commonly experience dyspnea, impaired skeletal muscle function and exercise 283 
intolerance.  284 
 285 
We reported a slightly increased HR during the ECC bout (~5 bpm, not statistically 286 
significant). This is in contrast to two previous studies in healthy individuals, where a lower 287 
hemodynamic burden (e.g. HR, BP) was reported during ECC compared to CON exercise 288 
(11, 36). We speculate that our findings reflect the unfamiliar ECC cycling stimulus, which 289 
our previous work shows can potentially exaggerate HR response, and that HR during ECC 290 
cycling decreases with repeated exposures (36).  Previous work by Penailillo et al. (36) 291 
indicated that the HR response to an initial bout of ECC exercise is exaggerated, with 292 
subsequent bouts of ECC at identical workloads eliciting a 12% lower HR response. The 293 
mechanisms underlying this are currently not well understood, however the authors 294 
speculated that this may be due to elevated metabolic stress or cycling efficiency experienced 295 
during an initial ECC session. Meyer et al. (27) examined coronary artery disease patients 296 
with preserved ventricular function and found HR during ECC was consistently higher than 297 
during CON across a 20-min protocol following 5 and 8 weeks of a training program. In 298 
contrast, significantly lower HRs during ECC were recorded by Besson et al. (4) in ECC 299 
trained patients with CHF. In a similar population, who also underwent a training program, 300 
Theodorou et al. (40) also reported lower HRs in the descending stair group following 6 301 
weeks of training, although no statistical analysis was provided. However, the subjective 302 
quantification of workload in these studies complicates interpretation of the results. In the 303 
present study, HR responses during ECC were not significantly different compared to CON 304 
at matched workloads. This may be related to the medication regimes of our participants, 305 
which attenuate HR and BP responses to exercise. Additionally, the difference between ECC 306 
and CON HR responses has been demonstrated to be intensity-dependent, with HR during 307 
concentric exercise increasing more steeply with increasing workload (11). It is therefore 308 
possible that the workload performed in this study was too light to reveal significant 309 
differences in HR between the two conditions. Similarly, BP and RPP responses did not 310 
significantly differ between the conditions. Given that RPP is an index of myocardial oxygen 311 
demand (16), this finding has important implications and indicates that ECC exercise can be 312 
performed with a similar hemodynamic response to CON exercise in patients with CHF. 313 
 314 
Average levels of BLa were higher following CON, although this did not reach statistical 315 
significance. These results are consistent with Perry et al. (37) and Dufour et al. (11) who 316 
reported that ECC BLa did not accumulate in healthy populations until participants had 317 
reached higher intensities (300 W) of cycling. Due to the low aerobic capacity in our 318 
participants (in comparison to healthy populations), average power output did not exceed 319 
90W during the exercise conditions. The average absolute (pre/post) change in BLa was 320 
therefore small but, importantly, was not higher under the ECC condition. 321 
 322 
Muscle soreness was significantly higher 24 and 48 hours after ECC compared to CON, 323 
despite the fact that we matched cadence at 40 rpm for both conditions, as ECC is better 324 
tolerated at slower speeds (6). These findings concur with those of Penailillo et al. (36) and 325 
Elmer et al. (12) Although eccentric contractions demonstrate mechanical efficiency through 326 
recruitment of fewer muscle fibers for a given level of tension (22, 39), increased muscle 327 
soreness occurs due to connective tissue damage and inflammation (23). Only responses to a 328 
single bout of ECC and CON were investigated in this study and we were therefore unable to 329 
examine the repeated bout effect, whereby muscle soreness decreases significantly following 330 
subsequent ECC bouts (30).  331 
 332 
Several limitations of the present study are germane. Due to the highly specific nature of our 333 
sample, our results cannot necessarily be extrapolated to all patients with cardiac-related 334 
conditions. Also, although several females underwent the screening process, only one 335 
satisfied the inclusion criteria. Thus, these results may not necessarily translate to females. 336 
The order of the exercise sessions was unable to be randomized because we needed to 337 
carefully assess ECC responses in order to match subsequent CON sessions. However, our 338 
approach did allow us to match the conditions for power output, allowing valid comparisons 339 
to be made.  340 
  341 
The present study investigated the responses to ECC and CON. Currently, this form of 342 
exercise requires relatively expensive ECC ergometers, which may be a barrier to its uptake 343 
for many cardiac rehabilitation programs. However, cycling is only one form of ECC 344 
exercise. Walking down hill, controlled lowering into a chair or lowering weights are all 345 
functional eccentric based movements requiring little expense while taking advantage of the 346 
unique properties of ECC contractions. Future studies should investigate if our promising 347 
results related to ECC are also applicable to these more accessible exercise options.  348 
 349 
In conclusion, this study has confirmed that, when matched for workload, ECC is performed 350 
at a lower oxygen demand in comparison to CON in patients with CHF. Furthermore, this can 351 
be attained with a similar hemodynamic demand. These findings suggest that greater external 352 
workloads may be achieved eccentrically, for a given oxygen demand thereby creating a 353 
foundation for further research. As functional capacity is severely restricted in patients with 354 
CHF, ECC exercise has potential to enhance much needed peripheral adaptations and 355 
functional capacity. 356 
 357 
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 384 
Figure legend 385 
Figure 1: Power outputs (W) during the 5 minute exercise protocol in the ECC and CON 386 
conditions. 387 
 388 
Figure 2: Difference in power output (W), V̇O2 (ml.kg-1.min-1), RER (ml.kg-1.min-1), and V̇E 389 
(L/min) between ECC and CON. Data are expressed as a percent (%) of ECC, illustrating a 390 
significantly higher power output (W), with a lower V̇O2, RER and V̇E during the ECC 391 
condition compared to the CON session.  392 
* P<0.01, # P<0.05 393 
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